CLINICAL ROLE -
Clinical Updates On COVID-19 Treatments and Vaccines
Even with the current available treatment options, it is important to recognize the importance of masking, particularly for those with immunocompromised conditions.
Read More
From the Pharmacy Counter to the World Stage: Public Speaking Champion Discusses Being a Go-Getter in Pharmacy
Lessons from the pharmacy taught her about good communication. Now it’s her turn to educate pharmacists.
Abelacimab Demonstrates Significant Reduction in Bleeding vs Rivaroxaban in Patients With Atrial Fibrillation
The AZALEA-TIMI 71 randomized trial evaluated the safety and tolerability of 2 blinded doses of the novel factor XI inhibitor abelacimab compared with open-label rivaroxaban.
Air Filter Box Introduces Innovative Technique to Trap Viruses
Homemade indoor air filters can trap and remove 99% of airborne viruses.
Genetic Biomarker Could Predict Food Allergy Reactions
The presence of the TPSAB1 gene could help clinicians identify increased food allergies.
Strategies to Help Eliminate Drug Exposure Risks in the Workplace
Safe handling of hazardous drugs plays a vital role in patient care.
Ensure Proper Use of Nonprescription Medications for Cold, Influenza, and COVID-19
Counseling is particularly important for pediatric patients or those with other medical conditions
Rivaroxaban Demonstrates Favorable Benefit-Risk Profile in Fragile Populations with Peripheral Arterial Disease
Bonaca also notes that pharmacists can play a key role in educating patients and clinicians about the appropriate use and dosing of antithrombotic drugs for vascular protection.
Watch
Upcoming Phase 3 Trials to Evaluate Efficacy, Safety of Milvexian in Patients with Cardiovascular Conditions
Harrington discusses how the performance of milvexian in prior phase 2 trials focused on different patient populations creates the foundation for future research.
Phase 3 Trial Demonstrates Benefits to Mavacamten Treatment in Hypertrophic Cardiomyopathy
Sehnert emphasizes that mavacamten treatment benefits were present in both patients with sarcomere mutation positive HCM and sarcomere mutation negative HCM.
Data Show Effect of Dietary Sodium Reduction on Blood Pressure Was Comparable to First-Line Medication
Clinically meaningful lowering of blood pressure through reduction in dietary sodium was achieved safely and rapidly in 1 week in a middle-aged and elderly cohort.
Data Show Lepodisiran Was Well Tolerated, Substantially Lowered Lipoprotein (a)
Elevated Lp(a), which was previously untreatable, may become treatable in the near future, according to the study investigator.
Data Show Benefit of Intensive Blood Pressure Reduction Is Consistent in East Asian Population With Hypertension, High Cardiovascular Risk
The SPRINT trial was the first to demonstrate the benefit of further reduction in blood pressure, but it included a limited Asian population and excluded patients with diabetes or history of stroke.
SELECT Trial Data Show Benefit of Semaglutide in Patients With Obesity
The SELECT trial expands on existing literature that have shown safety and cardiovascular benefit in individuals with diabetes to now also show benefit in obesity.
FDA Expands Indication of Regional Analgesic to Reduce Postsurgical Pain Without Opioids
Bupivacaine liposome injectable suspension was shown to reduce opioid use after surgery and significantly improve pain.
New Evidence in Recurrent Acute Tonsillitis in Adults Shows Benefit of Tonsillectomy Over Antibiotics
Throat indications contribute to high antibiotic overprescribing rates.
Implement Strategies Now to Prevent Patient Death From Accidental Daily Methotrexate Dosing
Specifying a day of the week to take the medication could help avoid inadvertent daily dosing
Pharmacy Focus: Policy Edition - Navigating the Reimbursement Maze
Tune in to this episode of Pharmacy Focus: Policy Edition for an update on the ever-evolving landscape of pharmacy reimbursements, pharmacy benefit manager reform, and direct and indirect remuneration fees.
Listen
Cardiovascular-Kidney-Metabolic Syndrome Requires a Collaborative Approach to Treatment
The American Heart Association published a statement describing the cardiovascular-kidney-metabolic (CKM) construct, specifically highlighting treatment challenges for CKM syndrome.
Expert: Black Students Face Unique Challenges When Entering, Considering Pharmacy Residency Programs
Experts discuss challenges and recommendations for addressing diversity, equity, and inclusion in pharmacy programs for minority students.
Pharmacy Focus: Psychedelic Pharmacy- Investigating Psilocybin-Assisted Therapy
Jordan Sloshower, MD, MSc, describes his experience working in several clinical trials investigating psilocybin-assisted therapy.
FDA Approves First Vaccine to Prevent Infection from Chikungunya Virus
The vaccine provides treatment prevention for individuals that are high risk of exposure to the chikungunya virus.
FDA Approves Prophylactic Treatment for Adults, Pediatric Patients With Extremely Rare Blood-Clotting Disorder
The on-demand enzyme replacement therapy reduced acute thrombotic thrombocytopenic purpura events in patients who experience potentially fatal blood clotting.
Interactions Between Tumor Genes, Microenvironment Impact Treatment Response in Multiple Myeloma
The study findings provide the first in-depth look at the relationship between chromosomal changes in tumor cells and immune components of the tumor microenvironment.
Study Reports Higher Risk of Respiratory Disease Fatality in Summer Than Winter
Health policies to adapt to climate change must be altered to protect individuals with respiratory diseases in the warmer season.
FDA Accepts Supplemental Biologics License Application for Hadlima for Interchangeability With Humira
The sBLA was based on data from a clinical study assessing the pharmacokinetics of switching between adalimumab and adalimumab-bwwd for patients with moderate to severe plaque psoriasis.
Pharmacy Sees Surge in Legislative Activity to Regulate Specialty Drug Dispensing Practices in 2023
Twenty states proposed bills to prohibit white bagging and brown bagging policies this year.
New COVID-19 Vaccines Will Keep Pharmacy Staff Busy
Both newly approved shots possess activity against subvariant EG5.1, which represents an estimated 21.5% of currently circulating variants
Simultaneous Inhibition of Proteins May Slow Growth of Aggressive, Drug-Resistant Breast Cancer
Researchers determined that simultaneously targeting the BRD4 and LOXL2 proteins disrupts their interaction and inhibits the growth of triple-negative breast cancer cells.
With DSCSA Compliance Delay, Certain Requirements Still Require Action Now
Launching development of SOPs and communication with wholesalers is key.